Neoreviews
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
 Vol. 10 No. 5, May 2009
Right arrow E-Letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-Letters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burgos, A. E.
Right arrow Articles by Burke, B. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Burgos, A. E.
Right arrow Articles by Burke, B. L., Jr
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

NeoReviews Vol.10 No.5 2009 e222
© 2009 American Academy of Pediatrics

Neonatal Abstinence Syndrome

Anthony E. Burgos, MD, MPH*
Bryan L. Burke, Jr, MD{dagger}

* Department of Pediatrics, Stanford University, Palo Alto, Calif
{dagger} Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark

Despite the growing knowledge of recognition, treatment, and outcomes, NAS continues to challenge clinicians. An increasing number of women receiving prescribed medications for chronic pain conditions and mental illness also have changed the population needing prenatal counseling and postnatal monitoring. NAS develops in more than 50% of all newborns exposed to narcotics in utero, but the signs of withdrawal remain nonspecific, and couplet care or rooming-in on postpartum wards often hinders monitoring and evaluation. Several abstinence scoring systems can assist nurses and physicians in assessing the severity of withdrawal and providing appropriate therapy. Medical therapy is recommended for severe cases, and several medications have proven safe and effective. Although the duration of therapy varies, medications can be titrated so infants can tolerate mild symptoms of withdrawal, and the process can be monitored with abstinence scores. This article reviews the signs of NAS from various substances, existing abstinence scoring systems, current treatment and weaning strategies, and relevant points for prenatal counseling.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Academy of Pediatrics.